Ghanaian paediatric oncologist Dr. Emmanuella Amoako has been named the recipient of the 2026 Roux Prize, becoming the first Ghanaian to win the prestigious global award for outstanding contributions to population health.

The award, announced by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, recognises individuals who demonstrate exceptional use of health evidence and data to improve the lives of populations.

Dr. Amoako was honoured for her work in advancing childhood cancer care, particularly efforts aimed at promoting early diagnosis, improving access to treatment and strengthening survival outcomes for children diagnosed with cancer.

Her work has focused significantly on strengthening paediatric oncology services at the Cape Coast Teaching Hospital, where she has championed measures to improve the early detection of childhood cancers, referral pathways and access to specialised care.

IHME said her contribution illustrates the importance of translating health data and locally generated evidence into practical interventions, particularly in resource-constrained settings where access to specialised childhood cancer services remains a challenge.

As part of the recognition, Dr. Amoako will receive a US$100,000 prize for her contribution to improving population health through evidence-based approaches.

Her achievement adds to a growing list of recognitions for her work in healthcare delivery. She was recently named among Channel One TV’s Top 10 Community Legends, an initiative that celebrates individuals whose work has made a significant difference in their communities.

The Roux Prize was established in 2013 by philanthropists David and Barbara Roux to honour individuals who have demonstrated exceptional impact in population health through the innovative application of health evidence and data.

Dr. Amoako’s recognition places the spotlight on the potential of evidence-driven healthcare interventions developed within Ghana to address major health challenges and improve outcomes for vulnerable groups, particularly children.

Her work in paediatric oncology has also highlighted the importance of timely diagnosis and coordinated referral systems in improving the prospects of children with cancer, especially where specialist services are limited.

The 2026 award therefore represents not only a personal milestone for Dr. Amoako but also a significant recognition of Ghanaian expertise in using evidence to strengthen healthcare delivery.